运动赋权:在治疗糖尿病心肌疾病的多面解剖学
Congfei Chen1,2, Longfei Xu2, Kun Wang3
1Tianjin Key Laboratory of Exercise Physiology & Sports Medicine, Tianjin University of Sport, Tianjin, 301617, China.
Journal of cardiovascular translational research
|June 4, 2025
概括
运动疗法对糖尿病心肌疾病有希望,通过向新陈代谢和减少氧化应激来改善心脏功能. 对这些机制的进一步研究可以指导糖尿病心脏病的新治疗策略.
科学领域:
- 心脏病学 心脏病学
- 内分泌学 在内分泌学.
- 运动生理学 运动生理学
背景情况:
- 糖尿病心肌疾病导致糖尿病患者的心脏功能障碍,独立于其他心脏疾病.
- 细胞问题,如代谢受损和氧化应激,有助于心脏损伤.
- 目前药物治疗方法有限,人们对像运动这样的非药物治疗方法越来越感兴趣.
研究的目的:
- 探索运动对糖尿病心肌疾病有益的机制.
- 审查运动对心肌代谢,抗氧化能力,纤维化和微血管病变的影响.
- 突出最近的进展,并鼓励进一步研究以运动为基础的疗法.
主要方法:
- 在糖尿病心肌病模型中研究运动干预的研究文献综述.
- 对运动心脏保护作用背后的细胞和分子机制的分析.
- 综合当前关于运动对心脏代谢,氧化应激,纤维化和微血管功能的影响的研究.
主要成果:
- 运动表现出热效应,可能改善心肌代谢和抗氧化防御.
- 运动可以减轻与糖尿病相关的心脏纤维化和微血管病变.
- 了解这些机制对于制定有针对性的炼方案至关重要.
结论:
- 运动治疗是一种有前途的非药物治疗策略,用于治疗糖尿病心肌疾病.
- 需要对精确的分子通路进行进一步的研究,以优化治疗效益.
- 这篇评论强调了运动对抗糖尿病心脏病进展的潜力.
相关概念视频
Cardiomyopathy VI: Nursing Management
314
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
314
Cardiomyopathy V: Interprofessional Care
343
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
343
Myocarditis IV: Nursing Management
209
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
209
Cardiomyopathy III: Hypertrophic Cardiomyopathy
416
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
416
Heart Failure VII: Nursing Interventions
425
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
425
Cardiomyopathy II: Dilated Cardiomyopathy
480
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
480


